Cyclacel Pharmaceuticals Inc

Cyclacel Pharmaceuticals Inc

CYCC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$35.64M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cyclacel Pharmaceuticals IncCyclacel Pharmaceuticals Inc-0.2--22%--
$0.39

Current Fair Value

93.9% downside

Overvalued by 93.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$35.64 Million
Enterprise Value$31.85 Million
Earnings per Share$-6.45
Beta0.16
Outstanding Shares5,598,701

Return

Return on Equity-22.34%ROE
Return on Assets-20.37%
Return on Invested Capital-117.67%

Valuation & Multiples

P/E Ratio-0.25P/E Ratio
PEG0.36PEG
Price to Sales-Price to Sales
Price to Book Ratio6.37Price to Book Ratio
Enterprise Value to Revenue42.57
Enterprise Value to EBIT-3.78
Enterprise Value to Net Income-20
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 13, 2025
EPS Estimate
$-72.00
Consensus analyst estimate
Revenue Estimate
$25,000
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.62%▲ 3.56%
Total Invested$116,974▲ 2018.33%
Investors Holding9▲ 3.00%

About Bio Green Med Solution, Inc.

2,018 employees
CEO: Sing Ee Wong

A diversified company operating in both the fire protection and biopharmaceutical industries. It expanded its portfolio by acquiring Fitters Sdn. Bhd., a Malaysian fire protection products and services group. Focuses on advancing opportu...

Cyclacel Pharmaceuticals Insider Information FAQ

In the latest 13F quarter on Stockcircle, 4 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.